rational drug design The principals invested S2.3M (Fully-Diluted Equity Ownership: —7.0%) in November 2012. Other Investors include Atlas Venture, SR One, Lilly Ventures and Schrodinger (9.5%). Research Gate ResearchCate is developing a social networking site for the research scientist community. At